These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7241891)

  • 1. Aluminum removal by hemodialysis.
    Graf H; Stummvoll HK; Meisinger V; Kovarik J; Wolf A; Pinggera WF
    Kidney Int; 1981 Apr; 19(4):587-92. PubMed ID: 7241891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Aluminum-balance during haemodialysis (author's transl)].
    Graf H; Stummvoll HK; Kovarik J; Meisinger V; Wolf A; Pinggera WF
    Wien Klin Wochenschr; 1980; 92(11):391-4. PubMed ID: 7424016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of desferrioxamine on aluminum kinetics during hemodialysis.
    Stummvoll HK; Graf H; Meisinger V
    Miner Electrolyte Metab; 1984; 10(4):263-6. PubMed ID: 6749073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aluminum transport and dialysance during haemodialysis.
    Hosokawa S; Nishitani H; Nishio T; Imai T; Tomita Y; Tomoyoshi T; Sawanishi K; Yoshida O
    Int Urol Nephrol; 1988; 20(1):89-100. PubMed ID: 3360590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Citrate compared to low molecular weight heparin anticoagulation in chronic hemodialysis patients.
    Janssen MJ; Deegens JK; Kapinga TH; Beukhof JR; Huijgens PC; van Loenen AC; van der Meulen J
    Kidney Int; 1996 Mar; 49(3):806-13. PubMed ID: 8648924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative evaluation of bone aluminum content and bone histology in patients on chronic hemodialysis and hemofiltration.
    Sebert JL; Fournier A; Leflon P; Fohrer P; de Frémont JF; Morinière P; Galy C; Marie A; Demontis R; Boudailliez B
    Nephron; 1986; 42(1):34-40. PubMed ID: 3941748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aluminum kinetics using bicarbonate dialysate with the sorbent system.
    Llach F; Gardner PW; George CR; Cairoli O
    Kidney Int; 1993 Apr; 43(4):899-902. PubMed ID: 8479127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative assessment of carnitine loss during hemodialysis and hemofiltration.
    Leschke M; Rumpf KW; Eisenhauer T; Fuchs C; Becker K; Köthe U; Scheler F
    Kidney Int Suppl; 1983 Dec; 16():S143-6. PubMed ID: 6588245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desferrioxamine induced aluminium removal in haemodialysis.
    Bonal J; Montoliu J; Löpez Pedret J; Bergadä E; Andrew L; Bachs M; Revert L
    Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():366-70. PubMed ID: 3991524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aluminum concentrations in serum of hemodialysis patients.
    Gorsky JE; Dietz AA
    Clin Chem; 1981 Jun; 27(6):932-5. PubMed ID: 7237778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence of increased parathyroid activity on discontinuation of high-aluminum dialysate in patients undergoing hemodialysis.
    O'Hare JA; Murnaghan DJ
    Am J Med; 1984 Aug; 77(2):229-32. PubMed ID: 6431809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hyperaluminemia in chronic hemodialysis patients. Evaluation of the respective roles of dialysate aluminum and oral aluminum hydroxide].
    Tahiri Y; Moriniere P; Jaudon MC; Dkhissi H; Rosa A; Fournier A
    Nephrologie; 1983; 4(3):129-33. PubMed ID: 6633778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Initial evaluation of aluminum concentrations in patients with nephropathy and undergoing hemodialysis at the Miguel Pérez Carreño Hospital and the University Hospital of Caracas (Venezuela)].
    Parra OE; Navarro JA; de Ardila M; Weissinger J; Domínguez J; Gutiérrez LE; Carlini R; Mendoza JA; Salgado OJ; Romero RA
    Invest Clin; 1989; 30(4):193-203. PubMed ID: 2488708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum concentration and peritoneal transfer of aluminum during treatment by continuous ambulatory peritoneal dialysis.
    Rottembourg J; Gallego JL; Jaudon MC; Clavel JP; Legrain M
    Kidney Int; 1984 Jun; 25(6):919-24. PubMed ID: 6471674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium exposure and removal in chronic hemodialysis patients.
    Sigrist M; McIntyre CW
    J Ren Nutr; 2006 Jan; 16(1):41-6. PubMed ID: 16414440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aluminum kinetics in patients treated with hemodialysis or hemofiltration with sorbent recycling of ultrafiltrate.
    Shapiro WB; Schilb TP; Porush JG
    Trans Am Soc Artif Intern Organs; 1984; 30():342-6. PubMed ID: 6533906
    [No Abstract]   [Full Text] [Related]  

  • 17. Aluminum, zinc and copper concentrations in plasma in chronic renal insufficiency.
    Zumkley H; Bertram HP; Lison A; Knoll O; Losse H
    Clin Nephrol; 1979 Jul; 12(1):18-21. PubMed ID: 477052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma aluminum levels in pediatric dialysis patients: comparison of hemodialysis and continuous ambulatory peritoneal dialysis.
    Milliner DS; Malekzadeh M; Lieberman E; Coburn JW
    Mayo Clin Proc; 1987 Apr; 62(4):269-74. PubMed ID: 3561041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid removal of DFO-chelated aluminum during hemodialysis using polysulfone dialyzers.
    Molitoris BA; Alfrey AC; Alfrey PS; Miller NL
    Kidney Int; 1988 Jul; 34(1):98-101. PubMed ID: 3172641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pO2 and pCO2 increment in post-dialyzer blood: the role of dialysate.
    Sombolos KI; Bamichas GI; Christidou FN; Gionanlis LD; Karagianni AC; Anagnostopoulos TC; Natse TA
    Artif Organs; 2005 Nov; 29(11):892-8. PubMed ID: 16266303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.